Abstract:Objective: To investigate the association between long-term fine particulate matter(PM_(2.5)) exposure and the risk of chronic kidney disease(CKD) in people with abnormal metabolism syndrome(MS) components. Methods: Based on health checkup data from a hospital in Beijing, a retrospective cohort study was used to collect annual checkup data from 2013-2019. A questionnaire was used to obtain information on demographic characteristics and lifestyle habits. We measured blood pressure, height, weight, waist circumference, concentrations of triglycerides(TG), fasting glucose, and high-density lipoprotein cholesterol(HDL-C). Longitude and latitude were also extracted from the addresses of the study subjects for pollutant exposure data estimation. Logistic regression models were used to explore the estimated effect of long-term PM_(2.5) exposure on the risk of CKD prevalence in people with abnormal MS components. Two-pollutant and multi-pollutant models were developed to test the stability of these result. Subgroup analysis was conducted based on age, the presence of MS, individual MS component abnormalities, and dual-component MS abnormalities. Results: The study included 1540 study subjects with abnormal MS components at baseline, 206 with CKD during the study period. The association between long-term PM_(2.5) exposure and increased risk of CKD in people with abnormal MS fractions was statistically significant, with a 2.26-fold increase in risk of CKD for every 10 μg/m~3 increase in PM_(2.5) exposure(OR=3.26, 95% CI 2.72-3.90). The result in the dual-pollutant models and multi-pollutant models suggested that the association between long-term PM_(2.5) exposure and increased risk of CKD in people with abnormal MS fractions remained stable after controlling for contemporaneous confounding by other air pollutants. The result of subgroup analysis revealed that individuals aged 45 or older, without MS, with TG<1.7 mmol/L, HDL-C≥1.04 mmol/L, without hypertension, and with central obesity and high blood sugar had a stronger association between PM_(2.5) exposure and CKD-related health effects. Conclusion: Long-term exposure to PM_(2.5) may increase the risk of CKD in people with abnormal MS components. More attention should be paid to middle-aged and elderly people aged ≥45 years, people with central obesity and hyperglycemia.

Association between metabolic syndrome and proteinuria in chronic kidney disease

The Prevalence of Microalbuminuria and Its Relationships with the Components of Metabolic Syndrome in the General Population of China

Analysis of the association between glomerular filtration rate, proteinuria and metabolic syndrome in chronic kidney patients based on longitudinal data

Relationship between Metabolic Syndrome and Chronic Kidney Disease

Metabolic Syndrome Without Diabetes or Hypertension Still Necessitates Early Screening for Chronic Kidney Disease: Information from a Chinese National Cross-Sectional Study

Metabolic Syndrome and Chronic Kidney Disease in General Chinese Adults: Results from the 2007-08 China National Diabetes and Metabolic Disorders Study

Association of Metabolic Syndrome with the Incidence of Low-Grade Albuminuria: a Cohort Study in Middle-Aged and Elderly Chinese Adults.

The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults

A study on the associations between reduced kidney function and metabolic syndrome and its components

Metabolic Syndrome and Chronic Kidney Disease in a Chinese Population Aged 40 Years and Older.

Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor

Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis.

The association of metabolic syndrome components and chronic kidney disease in patients with hypertension

Association of metabolic syndrome and IgA nephropathy

Prevalence of chronic kidney disease and its association with metabolic diseases: a cross-sectional survey in Zhejiang province, Eastern China

Metabolic syndrome as a risk factor for the development of kidney dysfunction: a meta-analysis of observational cohort studies

Metabolic syndrome severity score and the progression of CKD

[Association between exposure to PM_(2.5) and chronic kidney disease in a population with metabolic syndrome]

Study on Correlation of Microalbuminuria with Components of Metabolic Syndrome

Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex)

Metabolic Syndrome in Peritoneal Dialysis Patients: Choice of Diagnostic Criteria and Prognosis